[DPHARMA] QoQ Cumulative Quarter Result on 31-Mar-2022 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Mar-2022 [#1]
Profit Trend
QoQ- -69.11%
YoY- 15.2%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 696,717 544,757 367,683 185,941 639,175 493,731 321,893 67.09%
PBT 84,851 69,504 48,119 26,646 82,983 65,856 43,373 56.22%
Tax -14,739 -16,553 -11,517 -6,355 -17,300 -15,889 -10,369 26.34%
NP 70,112 52,951 36,602 20,291 65,683 49,967 33,004 65.02%
-
NP to SH 70,112 52,951 36,602 20,291 65,683 49,967 33,004 65.02%
-
Tax Rate 17.37% 23.82% 23.93% 23.85% 20.85% 24.13% 23.91% -
Total Cost 626,605 491,806 331,081 165,650 573,492 443,764 288,889 67.32%
-
Net Worth 657,045 647,522 634,375 621,987 621,564 612,147 614,350 4.56%
Dividend
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Div 21,901 4,761 4,734 - 21,660 4,708 3,530 236.52%
Div Payout % 31.24% 8.99% 12.93% - 32.98% 9.42% 10.70% -
Equity
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Net Worth 657,045 647,522 634,375 621,987 621,564 612,147 614,350 4.56%
NOSH 952,239 952,239 952,239 941,765 941,765 941,765 706,330 21.97%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 10.06% 9.72% 9.95% 10.91% 10.28% 10.12% 10.25% -
ROE 10.67% 8.18% 5.77% 3.26% 10.57% 8.16% 5.37% -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 73.17 57.21 38.83 20.03 67.87 52.43 45.58 36.98%
EPS 7.39 5.59 3.88 2.19 6.98 5.31 4.67 35.68%
DPS 2.30 0.50 0.50 0.00 2.30 0.50 0.50 175.82%
NAPS 0.69 0.68 0.67 0.67 0.66 0.65 0.87 -14.28%
Adjusted Per Share Value based on latest NOSH - 941,765
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 72.37 56.59 38.19 19.32 66.40 51.29 33.44 67.07%
EPS 7.28 5.50 3.80 2.11 6.82 5.19 3.43 64.92%
DPS 2.28 0.49 0.49 0.00 2.25 0.49 0.37 235.00%
NAPS 0.6825 0.6726 0.659 0.6461 0.6457 0.6359 0.6382 4.56%
Price Multiplier on Financial Quarter End Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 -
Price 1.61 1.30 1.20 1.49 1.68 1.81 3.03 -
P/RPS 2.20 2.27 3.09 7.44 2.48 3.45 6.65 -52.06%
P/EPS 21.87 23.38 31.04 68.17 24.09 34.11 64.83 -51.44%
EY 4.57 4.28 3.22 1.47 4.15 2.93 1.54 106.09%
DY 1.43 0.38 0.42 0.00 1.37 0.28 0.17 312.00%
P/NAPS 2.33 1.91 1.79 2.22 2.55 2.78 3.48 -23.41%
Price Multiplier on Announcement Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 23/02/23 09/11/22 16/08/22 17/05/22 15/02/22 18/11/21 17/08/21 -
Price 1.65 1.39 1.34 1.51 1.60 1.62 2.49 -
P/RPS 2.26 2.43 3.45 7.54 2.36 3.09 5.46 -44.37%
P/EPS 22.41 25.00 34.66 69.08 22.94 30.53 53.28 -43.77%
EY 4.46 4.00 2.88 1.45 4.36 3.28 1.88 77.59%
DY 1.39 0.36 0.37 0.00 1.44 0.31 0.20 262.90%
P/NAPS 2.39 2.04 2.00 2.25 2.42 2.49 2.86 -11.25%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment